Researchers have sought to determine better ways to manage patients with SCD experiencing pain or a vaso-occlusive sickle cell crisis.
Researchers sought to determine the allocation and cost involved with CAR-T therapy for patients with multiple myeloma.
Oncology professionals share what #MedTwitter means to them and where they might go if Twitter (now X) becomes obsolete.
Housing insecurity can impede patients’ access to cancer screening, treatment, and survivorship care, increasing the risk of poor outcomes.
Recent data reveal a staggering increase in reports of burnout among physicians.
As many as 55% of patients with cancer may be affected by food insecurity.
Researchers sought to determine whether AI in medicine in the form of synthetic data would be applicable for hematologic malignancies.
Researchers sought to determine whether a “twinning” program would improve pediatric ALL outcomes in LMICs.
As the costs of health care continue to increase, insurance reimbursements have become even more important for medical institutions to sustain their practices and expand optimal services.
Cancer patients may be particularly susceptible to transportation-related disruptions in care.
Is reticulocyte hemoglobin content a better marker of iron deficiency anemia than ferritin and other traditional serum measurements?
Researchers sought to determine ways to mitigate changes in visit rates among patients with hematologic neoplasms.
Researchers sought to determine the manifestations of sickle cell disease that are associated with pain and poor quality of life.
Lower ambulatory function was observed across 9 cancer types, with the strongest associations observed in patients with respiratory and oral cancers.
In fall 2021, staffers at Johnson Memorial Health were hoping they could finally catch their breath. They were just coming out of a weeks-long surge of covid-19 hospitalizations and deaths, fueled by the delta variant.
Researchers are investigating pirtobrutinib in patients with CLL, SLL, and MCL.
Experts describe how ChatGPT and other AI technologies will transform health care and research.
Oncology leaders testified before a House subcommittee about how drug shortages are hindering cancer care in the US and threatening the lives of patients.
Studies presented at the ASCO Annual Meeting 2023 highlighted new developments in lymphoma that could lead to changes in practice.
Researchers sought to create patient-derived iPSC models that represent all major genetic classes of human acute myeloid leukemia, including the survival rate.
Since the US Supreme Court overturned Roe v Wade last year, restrictions on access to abortion have had a negative impact on cancer care.
Erica Johnson, MD, discusses strategies to combat health misinformation in the wake of updates released by the CDC on recommendations for COVID-19 vaccination.
New research raises questions about the applicability of expanded hematologic testing in cases of suspected child abuse or non-accidental trauma.
Shondra J Brown, FNP-BC, uses her platform to help Black professionals navigate predominantly White workplaces and encourages them not to conform.
In the last few years, cancer research has been hindered by the COVID-19 pandemic, Brexit, the war in Ukraine, and tensions between world superpowers.
Research has suggested that ART may increase the risk of pediatric cancers, but studies have shown conflicting results, and questions remain.
Researchers sought to address the needs of caregivers of patients with hematologic malignancies undergoing HSCT.
Researchers sought to determine the balance between the efficacy and toxicity when administering CAR T-cell therapy.
NMDP/Be The Match and the ASTCT seek to address inequities in HCT and cellular therapy.
How the retail giant will use the sensitive medical data it collects is among the concerns.
The withdrawn approvals of ibrutinib for relapsed/refractory MCL and MZL are likely to have a limited impact on patients, experts say.
Researchers sought to determine the considerations needed for patients with chronic myeloid leukemia who conceive or wish to become pregnant while receiving TKI therapy.
Researchers sought to better discriminate true MRD positivity for risk stratification in chronic lymphocytic leukemia and acute lymphoblastic leukemia in children.
Researchers are conducting phase 2 trials to assess various combination therapies, including BCMA, in patents with relapsed/refractory multiple myeloma.
Methods to prevent and treat COVID-19 in cancer patients have had to evolve alongside the SARS-CoV-2 virus.
Research presented at the 2023 Tandem Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR demonstrated favorable results for various types of lymphoma.
A central objective of addressing moral distress is to permit clinicians to effectively perform their professional functions and thus better help patients.
Researchers proposed that integrating standardized fertility care into SCD treatment is a requisite of high-quality, personalized care
The phase 3 PhALLCON trial showed a trend toward improved EFS in patients with Ph+ newly diagnosed ALL when treated with ponatinib compared with imatinib.
A review of the importance family, friends, and a support system have on the cancer journey and survival outcomes for young adults with cancer.
At EAHAD 2023, researchers reported positive results from trials of patients with hemophilia A and B, including those who are difficult to treat.
High drug prices and ongoing shortages may prompt cancer patients to buy treatments online and fall prey to illegitimate pharmacies.
Researchers sought to determine the utility of red blood cell transfusion in reducing bone marrow abnormalities in patients with SCD.
Timely discussions about end-of-life preferences can ensure patients with advanced cancer receive care that aligns with their goals, experts say.
Addressing moral distress means not just obtaining ethics consultation as needed but also dealing with the feeling of powerlessness that often accompanies it.
Researchers sought to determine whether there were delays in or discontinuation of treatment for cancer among different populations during the COVID-19 pandemic.
The FBI and other federal agencies have issued warnings about a ransomware and data extortion group called the Daixin Team.
Researchers are conducting phase 2 and 3 trials to investigate novel treatment combinations for patients with DLBCL.
AANP and AAPA Presidents discuss how elimination of the X-Waiver and patient caps for buprenorphine prescription for opioid use disorder will affect clinical practice.
AML research presented at ASH 2022 highlighted promising combination regimens and suggested that some patients may benefit from less intensive treatment.